eBreathie is a pioneering digital health startup offering an integrated asthma management solution. The company's system includes a smart inhaler, which not only tracks WHEN patients take their medication but also HOW they do it, creating a detailed inhalation profile for each use. This is paired with a user-friendly mobile app for patients and a comprehensive patient management platform for doctors, providing real-time feedback on inhalation efficacy. Leveraging IoT and AI, eBreathie aims to reduce emergency visits, asthma attacks, and hospitalizations while ensuring effective inhalation techniques and optimal patient care. Founded in 2021 in Portugal, the startup received a €25.00K grant investment on 12 July 2023 from EIT Health. This innovative approach to asthma management positions eBreathie as a promising player in the Health Care and Manufacturing industries.
No recent news or press coverage available for eBreathie.